Ocular Therapeutix joins UBS Global Biopharma Conference fireside chat
OCUL•Ocular Therapeutix CEO Pravin U. Dugel will present at the UBS Global Biopharma Conference in London on Nov. 17, 2026.
1. Conference appearances
Ocular Therapeutix will attend the UBS Global Biopharma Conference in London on Nov. 17, 2026, where CEO Pravin U. Dugel will present. Chief Scientific Officer Jeffrey S. Heier will present at the Empire Forum in New York on Nov. 5, and the company will participate in OSN New York and OSN New York Retina from Nov. 6-8, including a Nov. 7 symposium on nAMD management.
